| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | ATP8B3 TPTE SLC36A1 ABCA12 SLCO2B1 CETP SLC6A17 TRPC1 TPTE2 MFSD9 MFSD4A SLC6A15 SLC46A1 SLC10A7 SLC29A2 SLC7A11 ATP10A SLC18B1 CHRNA1 MFSD12 SLC36A2 RYR2 SLC26A8 ABCA6 ABCA5 SLC50A1 SLC2A6 SLCO1A2 LRP2 SLC35F2 ATP11A SLC5A12 SLC26A11 PLP2 SLC16A10 | 7.84e-09 | 1289 | 185 | 35 | GO:0005215 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8I2 OR5B3 OR10A2 OR2T27 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR10D4P OR8A1 OR4C3 OR4C15 OR10H2 OR4A15 OR1D5 OR4B1 OR51V1 | 2.12e-08 | 431 | 185 | 19 | GO:0004984 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.86e-08 | 11 | 185 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8I2 OR5B3 OR10A2 OR2T27 GPR37L1 OR2AG2 TAAR2 OR6C68 OR10C1 OR14C36 LGR5 OR10J1 ADGRG4 OR8B8 OR10D4P OR8A1 OR4C3 TAS2R7 ADRB3 OR4C15 OR10H2 OR4A15 OR1D5 RXFP4 OR4B1 OR51V1 ADGRL3 | 4.88e-08 | 884 | 185 | 27 | GO:0004930 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC36A1 SLCO2B1 SLC6A17 SLC6A15 SLC46A1 SLC10A7 SLC7A11 SLC18B1 MFSD12 SLC36A2 SLC26A8 SLCO1A2 SLC5A12 SLC26A11 SLC16A10 | 1.17e-07 | 296 | 185 | 15 | GO:0015291 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.21e-07 | 14 | 185 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR8I2 OR5B3 OR10A2 OR2T27 GPR37L1 OR2AG2 TAAR2 OR6C68 OR10C1 TNFRSF10D OR14C36 LGR5 OR10J1 CHRNA1 ADGRG4 NRP2 OR8B8 OR10D4P OR8A1 OR4C3 TAS2R7 ADRB3 OR4C15 EBI3 OR10H2 PTPRZ1 OR4A15 OR1D5 RXFP4 OR4B1 OR51V1 ADGRL3 IL9R | 2.79e-07 | 1353 | 185 | 33 | GO:0004888 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TPTE SLC36A1 ABCA12 SLCO2B1 SLC6A17 TRPC1 TPTE2 MFSD9 MFSD4A SLC6A15 SLC46A1 SLC10A7 SLC29A2 SLC7A11 SLC18B1 CHRNA1 MFSD12 SLC36A2 RYR2 SLC26A8 ABCA6 ABCA5 SLC50A1 SLC2A6 SLCO1A2 SLC35F2 SLC5A12 SLC26A11 PLP2 SLC16A10 | 4.44e-07 | 1180 | 185 | 30 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC36A1 ABCA12 SLCO2B1 SLC6A17 SLC6A15 SLC46A1 SLC10A7 SLC7A11 SLC18B1 MFSD12 SLC36A2 SLC26A8 ABCA6 ABCA5 SLCO1A2 SLC5A12 SLC26A11 SLC16A10 | 5.08e-07 | 477 | 185 | 18 | GO:0022804 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC36A1 SLCO2B1 SLC6A15 SLC46A1 SLC10A7 SLC7A11 MFSD12 SLC36A2 SLC26A8 SLCO1A2 SLC5A12 SLC16A10 | 5.44e-07 | 207 | 185 | 12 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC36A1 SLCO2B1 SLC6A15 SLC46A1 SLC10A7 SLC7A11 MFSD12 SLC36A2 SLC26A8 SLCO1A2 SLC5A12 SLC16A10 | 5.72e-07 | 208 | 185 | 12 | GO:0005342 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC36A1 SLCO2B1 SLC6A15 SLC46A1 SLC10A7 SLC7A11 MFSD12 SLC36A2 SLC26A8 SLC2A6 SLCO1A2 SLC5A12 SLC26A11 SLC16A10 | 6.36e-07 | 293 | 185 | 14 | GO:0008514 |
| GeneOntologyMolecularFunction | L-tyrosine transmembrane transporter activity | 7.83e-07 | 3 | 185 | 3 | GO:0005302 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.07e-06 | 37 | 185 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.17e-06 | 21 | 185 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.26e-06 | 38 | 185 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | lipid transporter activity | ATP8B3 ABCA12 SLCO2B1 CETP SLC10A7 ATP10A ABCA6 ABCA5 SLCO1A2 ATP11A | 1.51e-05 | 196 | 185 | 10 | GO:0005319 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.22e-05 | 37 | 185 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.53e-05 | 38 | 185 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6.51e-05 | 46 | 185 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | symporter activity | SLC36A1 SLC6A17 SLC6A15 SLC46A1 SLC10A7 MFSD12 SLC36A2 SLC5A12 | 8.01e-05 | 150 | 185 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | proline:proton symporter activity | 8.54e-05 | 2 | 185 | 2 | GO:0005297 | |
| GeneOntologyMolecularFunction | phosphatidyl phospholipase B activity | 1.22e-04 | 11 | 185 | 3 | GO:0102545 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 1.23e-04 | 28 | 185 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 1.62e-04 | 30 | 185 | 4 | GO:0052866 | |
| GeneOntologyMolecularFunction | aromatic amino acid transmembrane transporter activity | 2.09e-04 | 13 | 185 | 3 | GO:0015173 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 2.53e-04 | 61 | 185 | 5 | GO:1901682 | |
| GeneOntologyMolecularFunction | floppase activity | 4.01e-04 | 16 | 185 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 4.39e-04 | 105 | 185 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate phosphatase activity | 5.06e-04 | 4 | 185 | 2 | GO:0106017 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 5.53e-04 | 41 | 185 | 4 | GO:0015175 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | TNFRSF10D BIRC6 SERPINA4 PSME4 SERPINB3 SERPINB4 TIMM50 ITIH6 SERPINA5 | 6.78e-04 | 257 | 185 | 9 | GO:0061134 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 8.37e-04 | 79 | 185 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity | 8.38e-04 | 5 | 185 | 2 | GO:0016314 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.05e-03 | 83 | 185 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | odorant binding | 1.19e-03 | 127 | 185 | 6 | GO:0005549 | |
| GeneOntologyMolecularFunction | amino acid:proton symporter activity | 1.25e-03 | 6 | 185 | 2 | GO:0005280 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.27e-03 | 51 | 185 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.44e-03 | 231 | 185 | 8 | GO:0005085 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.50e-03 | 90 | 185 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 1.55e-03 | 25 | 185 | 3 | GO:0015295 | |
| GeneOntologyMolecularFunction | L-proline transmembrane transporter activity | 1.74e-03 | 7 | 185 | 2 | GO:0015193 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate phosphatase activity | 1.94e-03 | 27 | 185 | 3 | GO:0034593 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 2.39e-03 | 29 | 185 | 3 | GO:0005416 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 2.39e-03 | 29 | 185 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | lysophospholipase activity | 2.39e-03 | 29 | 185 | 3 | GO:0004622 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 2.74e-03 | 201 | 185 | 7 | GO:0061135 | |
| GeneOntologyMolecularFunction | thyroid hormone transmembrane transporter activity | 2.94e-03 | 9 | 185 | 2 | GO:0015349 | |
| GeneOntologyMolecularFunction | L-alanine transmembrane transporter activity | 2.94e-03 | 9 | 185 | 2 | GO:0015180 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 2.94e-03 | 9 | 185 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 2.96e-03 | 105 | 185 | 5 | GO:0004867 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ANPEP NPEPPS CASP10 TMPRSS5 ERVK-7 ERVK-10 OVCH1 USP8 ERVK-8 ERVK-18 ERVK-25 USP39 CFAP44 | 3.18e-03 | 654 | 185 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | glycine transmembrane transporter activity | 3.66e-03 | 10 | 185 | 2 | GO:0015187 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 3.79e-03 | 34 | 185 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 4.06e-03 | 70 | 185 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 4.27e-03 | 71 | 185 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | sulfur amino acid transmembrane transporter activity | 4.44e-03 | 11 | 185 | 2 | GO:0000099 | |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 4.44e-03 | 11 | 185 | 2 | GO:0008271 | |
| GeneOntologyMolecularFunction | phosphatidylinositol trisphosphate phosphatase activity | 4.44e-03 | 11 | 185 | 2 | GO:0034594 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 4.72e-03 | 73 | 185 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 4.82e-03 | 37 | 185 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 4.96e-03 | 74 | 185 | 4 | GO:0005548 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.05e-03 | 119 | 185 | 5 | GO:0015294 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR8I2 OR5B3 OR10A2 OR2T27 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR10D4P OR8A1 OR4C3 OR4C15 OR10H2 OR4A15 OR1D5 OR4B1 OR51V1 CFAP69 | 7.78e-09 | 465 | 185 | 20 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR8I2 OR5B3 OR10A2 OR2T27 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 RYR2 OR8B8 OR10D4P OR8A1 OR4C3 TAS2R7 OR4C15 OR10H2 OR4A15 OR1D5 OR4B1 OR51V1 | 1.10e-08 | 524 | 185 | 21 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR8I2 OR5B3 OR10A2 OR2T27 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR10D4P OR8A1 OR4C3 OR4C15 OR10H2 OR4A15 OR1D5 OR4B1 OR51V1 | 1.32e-08 | 432 | 185 | 19 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8I2 OR5B3 OR10A2 OR2T27 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR10D4P OR8A1 OR4C3 TAS2R7 OR4C15 OR10H2 OR4A15 OR1D5 OR4B1 OR51V1 | 1.57e-08 | 485 | 185 | 20 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8I2 OR5B3 OR10A2 OR2T27 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR10D4P OR8A1 OR4C3 TAS2R7 OR4C15 OR10H2 OR4A15 OR1D5 OR4B1 OR51V1 CFAP69 | 2.32e-08 | 547 | 185 | 21 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR8I2 OR5B3 OR10A2 OR2T27 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR10D4P OR8A1 EYS OR4C3 TAS2R7 OR4C15 OR10H2 OR4A15 OR1D5 OR4B1 OR51V1 | 6.66e-08 | 582 | 185 | 21 | GO:0050906 |
| GeneOntologyBiologicalProcess | DNA integration | 6.68e-08 | 13 | 185 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR8I2 OR5B3 OR10A2 OR2T27 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 RYR2 OR8B8 OR10D4P OR8A1 EYS OR4C3 TAS2R7 OR4C15 OR10H2 OR4A15 NMT2 OR1D5 OR4B1 OR51V1 | 1.44e-07 | 722 | 185 | 23 | GO:0051606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR8I2 FLNA OR5B3 OR10A2 OR2T27 TRPC1 GPR37L1 OR2AG2 TAAR2 OR6C68 OR10C1 OR14C36 LGR5 OR10J1 ADGRG4 ADCY8 OR8B8 OR10D4P OR8A1 OR4C3 TAS2R7 ADRB3 OR4C15 OR10H2 OR4A15 NMT2 OR1D5 RXFP4 OR4B1 RAPGEF2 OR51V1 ADGRL3 HTT | 2.68e-07 | 1395 | 185 | 33 | GO:0007186 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC36A1 SLCO2B1 SLC6A17 SLC6A15 SLC46A1 SLC10A7 SLC7A11 MFSD12 SLC36A2 PLIN2 SLC26A8 SLCO1A2 LRP2 SLC5A12 SLC26A11 SLC16A10 | 9.60e-07 | 410 | 185 | 16 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC36A1 SLCO2B1 SLC6A17 SLC6A15 SLC46A1 SLC10A7 SLC7A11 MFSD12 SLC36A2 PLIN2 SLC26A8 SLCO1A2 LRP2 SLC5A12 SLC26A11 SLC16A10 | 1.02e-06 | 412 | 185 | 16 | GO:0015849 |
| GeneOntologyBiologicalProcess | proline transport | 4.21e-06 | 13 | 185 | 4 | GO:0015824 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC36A1 SLCO2B1 SLC6A17 SLC6A15 SLC46A1 SLC10A7 SLC7A11 MFSD12 SLC36A2 PLIN2 SLC26A8 SLC2A6 SLCO1A2 LRP2 SLC5A12 SLC26A11 SLC16A10 | 4.22e-06 | 515 | 185 | 17 | GO:0015711 |
| GeneOntologyBiologicalProcess | sensory perception | HEXA OR8I2 OR5B3 OR10A2 OR2T27 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR10D4P OR8A1 EYS OR4C3 TAS2R7 OR4C15 OR10H2 CLRN3 OR4A15 OR1D5 LRP2 OR4B1 OR51V1 CFAP69 | 1.15e-05 | 1072 | 185 | 25 | GO:0007600 |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.61e-05 | 60 | 185 | 6 | GO:0015804 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 2.21e-05 | 94 | 185 | 7 | GO:0042440 | |
| GeneOntologyBiologicalProcess | organic cation transport | SLC36A1 SLC6A17 SLC6A15 SLC18B1 MFSD12 SLC36A2 SLCO1A2 SLC16A10 | 5.04e-05 | 145 | 185 | 8 | GO:0015695 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 6.89e-05 | 48 | 185 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | melanin biosynthetic process | 8.03e-05 | 26 | 185 | 4 | GO:0042438 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.02e-04 | 83 | 185 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | secondary metabolite biosynthetic process | 1.08e-04 | 28 | 185 | 4 | GO:0044550 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 1.15e-04 | 163 | 185 | 8 | GO:1905039 | |
| GeneOntologyBiologicalProcess | melanin metabolic process | 1.25e-04 | 29 | 185 | 4 | GO:0006582 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 1.35e-04 | 167 | 185 | 8 | GO:1903825 | |
| GeneOntologyBiologicalProcess | motile cilium assembly | 1.41e-04 | 88 | 185 | 6 | GO:0044458 | |
| GeneOntologyBiologicalProcess | sperm flagellum assembly | 1.45e-04 | 56 | 185 | 5 | GO:0120316 | |
| GeneOntologyBiologicalProcess | lipid localization | HEXA ATP8B3 ABCA12 SLCO2B1 CETP SLC10A7 GDF9 ATP10A PLIN2 ABCA6 ABCA5 SLCO1A2 VAMP7 ATP11A SERPINA5 | 1.84e-04 | 565 | 185 | 15 | GO:0010876 |
| GeneOntologyBiologicalProcess | lipid transport | ATP8B3 ABCA12 SLCO2B1 CETP SLC10A7 GDF9 ATP10A PLIN2 ABCA6 ABCA5 SLCO1A2 VAMP7 ATP11A SERPINA5 | 1.99e-04 | 506 | 185 | 14 | GO:0006869 |
| GeneOntologyBiologicalProcess | sperm axoneme assembly | 2.35e-04 | 34 | 185 | 4 | GO:0007288 | |
| GeneOntologyBiologicalProcess | folate import across plasma membrane | 2.39e-04 | 3 | 185 | 2 | GO:1904447 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 2.94e-04 | 65 | 185 | 5 | GO:0072348 | |
| GeneOntologyBiologicalProcess | glycine transport | 2.98e-04 | 15 | 185 | 3 | GO:0015816 | |
| GeneOntologyBiologicalProcess | regulation of secondary metabolite biosynthetic process | 3.65e-04 | 16 | 185 | 3 | GO:1900376 | |
| GeneOntologyBiologicalProcess | regulation of melanin biosynthetic process | 3.65e-04 | 16 | 185 | 3 | GO:0048021 | |
| GeneOntologyBiologicalProcess | regulation of secondary metabolic process | 3.65e-04 | 16 | 185 | 3 | GO:0043455 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 4.31e-04 | 108 | 185 | 6 | GO:0015807 | |
| GeneOntologyBiologicalProcess | alanine transport | 5.25e-04 | 18 | 185 | 3 | GO:0032328 | |
| GeneOntologyCellularComponent | apical part of cell | FAT4 PLB1 SLC36A1 DYNC2H1 SLCO2B1 SLC46A1 SLC29A2 SLC7A11 ADCY8 BTD SLCO1A2 VAMP7 LRP2 SLC5A12 RAPGEF2 SLC26A11 | 7.80e-05 | 592 | 185 | 16 | GO:0045177 |
| GeneOntologyCellularComponent | brush border membrane | 9.50e-05 | 83 | 185 | 6 | GO:0031526 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 2.31e-04 | 14 | 185 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | brush border | 4.17e-04 | 152 | 185 | 7 | GO:0005903 | |
| HumanPheno | Coiled sperm flagella | 1.49e-05 | 32 | 52 | 5 | HP:0032560 | |
| HumanPheno | Short sperm flagella | 1.74e-05 | 33 | 52 | 5 | HP:0032559 | |
| Domain | GPCR_Rhodpsn_7TM | OR8I2 OR5B3 OR10A2 OR2T27 GPR37L1 OR2AG2 TAAR2 OR6C68 OR10C1 OR14C36 LGR5 OR10J1 OR8B8 OR8A1 OR4C3 TAS2R7 ADRB3 OR4C15 OR10H2 OR4A15 OR1D5 RXFP4 OR4B1 OR51V1 | 3.08e-08 | 670 | 180 | 24 | IPR017452 |
| Domain | Olfact_rcpt | OR8I2 OR5B3 OR10A2 OR2T27 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR8A1 OR4C3 OR4C15 OR10H2 OR4A15 OR1D5 OR4B1 OR51V1 | 5.04e-08 | 393 | 180 | 18 | IPR000725 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8I2 OR5B3 OR10A2 OR2T27 GPR37L1 OR2AG2 TAAR2 OR6C68 OR10C1 OR14C36 LGR5 OR10J1 OR8B8 OR8A1 OR4C3 TAS2R7 ADRB3 OR4C15 OR10H2 OR4A15 OR1D5 RXFP4 OR4B1 OR51V1 | 5.50e-08 | 691 | 180 | 24 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8I2 OR5B3 OR10A2 OR2T27 GPR37L1 OR2AG2 TAAR2 OR6C68 OR10C1 OR14C36 LGR5 OR10J1 OR8B8 OR8A1 OR4C3 TAS2R7 ADRB3 OR4C15 OR10H2 OR4A15 OR1D5 RXFP4 OR4B1 OR51V1 | 5.65e-08 | 692 | 180 | 24 | IPR000276 |
| Domain | 7tm_1 | OR8I2 OR5B3 OR10A2 OR2T27 GPR37L1 OR2AG2 TAAR2 OR6C68 OR10C1 OR14C36 LGR5 OR10J1 OR8B8 OR8A1 OR4C3 ADRB3 OR4C15 OR10H2 OR4A15 OR1D5 RXFP4 OR4B1 OR51V1 | 1.58e-07 | 677 | 180 | 23 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8I2 OR5B3 OR10A2 OR2T27 GPR37L1 OR2AG2 TAAR2 OR6C68 OR10C1 OR14C36 LGR5 OR10J1 OR8B8 OR8A1 OR4C3 ADRB3 OR4C15 OR10H2 OR4A15 OR1D5 RXFP4 OR4B1 OR51V1 | 1.95e-07 | 685 | 180 | 23 | PS00237 |
| Domain | MFS_dom | SLCO2B1 MFSD9 MFSD4A SLC46A1 SLC29A2 SLC18B1 MFSD12 SLC2A6 SLCO1A2 SLC16A10 | 7.00e-07 | 134 | 180 | 10 | IPR020846 |
| Domain | MFS | 9.87e-06 | 108 | 180 | 8 | PS50850 | |
| Domain | UPF0028 | 9.24e-05 | 2 | 180 | 2 | PS01237 | |
| Domain | MFS_1 | 9.92e-05 | 77 | 180 | 6 | PF07690 | |
| Domain | MFS | 9.92e-05 | 77 | 180 | 6 | IPR011701 | |
| Domain | ABC_A | 1.82e-04 | 12 | 180 | 3 | IPR026082 | |
| Domain | Serpin_CS | 2.43e-04 | 32 | 180 | 4 | IPR023795 | |
| Domain | P_typ_ATPase_c | 2.96e-04 | 14 | 180 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 2.96e-04 | 14 | 180 | 3 | IPR032631 | |
| Domain | P-type_ATPase_IV | 2.96e-04 | 14 | 180 | 3 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 2.96e-04 | 14 | 180 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 2.96e-04 | 14 | 180 | 3 | PF16209 | |
| Domain | Serpin_dom | 3.86e-04 | 36 | 180 | 4 | IPR023796 | |
| Domain | SERPIN | 4.30e-04 | 37 | 180 | 4 | PS00284 | |
| Domain | SERPIN | 4.30e-04 | 37 | 180 | 4 | SM00093 | |
| Domain | Serpin | 4.77e-04 | 38 | 180 | 4 | PF00079 | |
| Domain | Serpin_fam | 5.27e-04 | 39 | 180 | 4 | IPR000215 | |
| Domain | FN3 | 7.07e-04 | 199 | 180 | 8 | PS50853 | |
| Domain | Na/ntran_symport_orphan | 9.06e-04 | 5 | 180 | 2 | IPR002438 | |
| Domain | FN3_dom | 9.72e-04 | 209 | 180 | 8 | IPR003961 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP8B3 SLC36A1 ABCA12 SLCO2B1 CETP TRPC1 SLC6A15 SLC46A1 SLC29A2 SLC7A11 ATP10A ADCY8 SLC36A2 RYR2 MICU3 PSME4 ABCA6 ABCA5 SLC50A1 SLC2A6 SLCO1A2 ATP11A SLC5A12 SLC26A11 UNC79 SLC16A10 | 1.58e-08 | 736 | 141 | 26 | M27287 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR8I2 OR5B3 OR10A2 OR2T27 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR8A1 OR4C3 OR4C15 OR10H2 OR4A15 OR1D5 OR4B1 OR51V1 | 6.37e-08 | 389 | 141 | 18 | M14091 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP8B3 SLC36A1 ABCA12 SLCO2B1 TRPC1 SLC6A15 SLC46A1 SLC29A2 SLC7A11 ATP10A SLC36A2 RYR2 MICU3 PSME4 ABCA6 ABCA5 SLC50A1 SLC2A6 SLCO1A2 ATP11A SLC5A12 SLC26A11 UNC79 SLC16A10 | 6.40e-08 | 681 | 141 | 24 | MM14985 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR8I2 OR5B3 OR10A2 OR2T27 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR8A1 OR4C3 OR4C15 OR10H2 OR4A15 OR1D5 OR4B1 OR51V1 | 1.81e-07 | 417 | 141 | 18 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR8I2 OR5B3 PLB1 OR10A2 OR2T27 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR8A1 OR4C3 TAS2R7 OR4C15 OR10H2 OR4A15 NMT2 OR1D5 LRP2 OR4B1 OR51V1 | 3.35e-07 | 636 | 141 | 22 | M41834 |
| Pathway | REACTOME_PI_METABOLISM | 1.89e-06 | 84 | 141 | 8 | M676 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC36A1 SLCO2B1 SLC6A15 SLC29A2 SLC7A11 SLC36A2 SLC50A1 SLC2A6 SLCO1A2 SLC5A12 SLC26A11 SLC16A10 | 4.74e-06 | 238 | 141 | 12 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC36A1 SLCO2B1 SLC6A15 SLC29A2 SLC7A11 SLC36A2 SLC50A1 SLC2A6 SLCO1A2 SLC5A12 SLC26A11 SLC16A10 | 7.52e-06 | 249 | 141 | 12 | M5988 |
| Pathway | REACTOME_PI_METABOLISM | 1.16e-05 | 77 | 141 | 7 | MM14590 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.51e-05 | 32 | 141 | 5 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.77e-05 | 33 | 141 | 5 | M188 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.04e-04 | 108 | 141 | 7 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.10e-04 | 109 | 141 | 7 | MM15074 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 2.70e-04 | 211 | 141 | 9 | M649 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 6.01e-04 | 17 | 141 | 3 | MM14552 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | 7.16e-04 | 18 | 141 | 3 | M645 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | 7.16e-04 | 18 | 141 | 3 | MM14642 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 7.16e-04 | 18 | 141 | 3 | M524 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 7.92e-04 | 196 | 141 | 8 | MM14591 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR8I2 OR5B3 OR10A2 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR10D4P OR8A1 OR4C3 OR4C15 OR4A15 OR1D5 OR4B1 OR51V1 | 6.15e-12 | 340 | 188 | 17 | 11875048 |
| Pubmed | OR8I2 OR5B3 OR10A2 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR10D4P OR8A1 OR4C3 OR4C15 OR4A15 OR1D5 OR4B1 OR51V1 | 6.15e-12 | 340 | 188 | 17 | 11802173 | |
| Pubmed | OR8I2 OR5B3 OR10A2 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR10D4P OR8A1 OR4C3 OR4C15 OR4A15 OR1D5 OR4B1 OR51V1 | 7.07e-12 | 343 | 188 | 17 | 32295537 | |
| Pubmed | OR8I2 OR5B3 OR10A2 OR2AG2 OR6C68 OR10C1 OR14C36 OR10J1 OR8B8 OR10D4P OR8A1 OR4C3 OR4C15 OR4A15 OR1D5 OR4B1 OR51V1 | 8.11e-12 | 346 | 188 | 17 | 14611657 | |
| Pubmed | OR8I2 OR5B3 OR10A2 OR2T27 OR2AG2 OR10C1 OR14C36 OR10J1 OR8B8 OR10D4P OR8A1 OR4C3 OR4C15 OR10H2 OR4A15 OR1D5 OR4B1 OR51V1 | 1.09e-09 | 541 | 188 | 18 | 14983052 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | OR8I2 OR10A2 OR2AG2 OR10C1 OR10J1 OR8B8 OR8A1 OR10H2 OR4A15 OR1D5 OR4B1 | 3.49e-08 | 219 | 188 | 11 | 12213199 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.19e-07 | 4 | 188 | 3 | 10469592 | |
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 6.63e-07 | 31 | 188 | 5 | 18195088 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 8.30e-07 | 94 | 188 | 7 | 21542922 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.54e-06 | 5 | 188 | 3 | 12629516 | |
| Pubmed | 2.38e-06 | 18 | 188 | 4 | 18664271 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 FAT4 IQSEC2 OBSCN FAM227B TMEM80 BIRC6 URB1 BTD ATAD2B LRP2 OR4B1 USP39 CFAP44 SLC26A11 MTMR9 | 2.86e-06 | 736 | 188 | 16 | 29676528 |
| Pubmed | Genomic analysis of orthologous mouse and human olfactory receptor loci. | 1.27e-05 | 9 | 188 | 3 | 11416212 | |
| Pubmed | The human ATP-binding cassette (ABC) transporter superfamily. | 1.81e-05 | 10 | 188 | 3 | 11435397 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 15203214 | ||
| Pubmed | Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure. | 2.91e-05 | 2 | 188 | 2 | 23354406 | |
| Pubmed | The COOH-terminal domain of huntingtin interacts with RhoGEF kalirin and modulates cell survival. | 2.91e-05 | 2 | 188 | 2 | 29789657 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 11959859 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 35533267 | ||
| Pubmed | Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. | 2.91e-05 | 2 | 188 | 2 | 12640454 | |
| Pubmed | The Effects of N-Glycosylation on the Expression and Transport Activity of OATP1A2 and OATP2B1. | 2.91e-05 | 2 | 188 | 2 | 38432624 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 25132355 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 34886853 | ||
| Pubmed | Characterization of novel squamous cell carcinoma antigen-related molecules in mice. | 2.91e-05 | 2 | 188 | 2 | 15504361 | |
| Pubmed | SCCA2-like serpins mediate genetic predisposition to skin tumors. | 2.91e-05 | 2 | 188 | 2 | 12702576 | |
| Pubmed | Synaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport. | 2.91e-05 | 2 | 188 | 2 | 19147495 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 9285789 | ||
| Pubmed | Lysoptosis is an evolutionarily conserved cell death pathway moderated by intracellular serpins. | 2.91e-05 | 2 | 188 | 2 | 35022507 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 25111616 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 31776261 | ||
| Pubmed | Squamous cell carcinoma antigen production in nasal inverted papilloma. | 2.91e-05 | 2 | 188 | 2 | 23168150 | |
| Pubmed | Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. | 2.91e-05 | 2 | 188 | 2 | 14970861 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 28270177 | ||
| Pubmed | Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington's disease. | 2.91e-05 | 2 | 188 | 2 | 32897880 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 10653592 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 29112685 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 10956412 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 35874657 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 22406480 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 29049335 | ||
| Pubmed | Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy. | 2.91e-05 | 2 | 188 | 2 | 27668655 | |
| Pubmed | Squamous cell carcinoma antigen and cancer antigen 125 in southern Indian cervical cancer patients. | 2.91e-05 | 2 | 188 | 2 | 21338226 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 18086666 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 21566141 | ||
| Pubmed | Serpinb3 is overexpressed in the liver in presence of iron overload. | 2.91e-05 | 2 | 188 | 2 | 28935635 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 21679149 | ||
| Pubmed | Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. | 2.91e-05 | 2 | 188 | 2 | 21403642 | |
| Pubmed | SLC46A1 Haplotype with Predicted Functional Impact has Prognostic Value in Breast Carcinoma. | 2.91e-05 | 2 | 188 | 2 | 33387348 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 11267667 | ||
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 29491058 | ||
| Pubmed | The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. | 2.91e-05 | 2 | 188 | 2 | 11863458 | |
| Pubmed | IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. | 2.91e-05 | 2 | 188 | 2 | 22808225 | |
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 2.91e-05 | 2 | 188 | 2 | 11672541 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 22164291 | ||
| Pubmed | The Proteasome Activators Blm10/PA200 Enhance the Proteasomal Degradation of N-Terminal Huntingtin. | 2.91e-05 | 2 | 188 | 2 | 33233776 | |
| Pubmed | 2.91e-05 | 2 | 188 | 2 | 20428762 | ||
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 3.22e-05 | 67 | 188 | 5 | 21875946 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | FLNA ANPEP NCKAP1 KALRN DYNC2H1 CETP NPEPPS SLC36A2 EYS SERPINA4 CLRN3 SERPINB3 VAMP7 LRP2 SLC5A12 SLC26A11 SERPINA5 | 4.11e-05 | 1016 | 188 | 17 | 19056867 |
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 4.27e-05 | 13 | 188 | 3 | 11015572 | |
| Pubmed | 6.63e-05 | 126 | 188 | 6 | 17897319 | ||
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 7.13e-05 | 79 | 188 | 5 | 12679517 | |
| Pubmed | KNTC1 DYNC2H1 SLCO2B1 BIRC6 WDFY4 ATP10A PIKFYVE RGL1 SACS ASTN2 ATP11A | 8.46e-05 | 493 | 188 | 11 | 15368895 | |
| Pubmed | 8.65e-05 | 43 | 188 | 4 | 24172014 | ||
| Pubmed | Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC Patients. | 8.69e-05 | 3 | 188 | 2 | 23712355 | |
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 28901315 | ||
| Pubmed | CMYA5 establishes cardiac dyad architecture and positioning. | 8.69e-05 | 3 | 188 | 2 | 35449169 | |
| Pubmed | Targeting ENT1 and adenosine tone for the treatment of Huntington's disease. | 8.69e-05 | 3 | 188 | 2 | 28069792 | |
| Pubmed | Organization and expression of the SLC36 cluster of amino acid transporter genes. | 8.69e-05 | 3 | 188 | 2 | 15058382 | |
| Pubmed | A cluster of proton/amino acid transporter genes in the human and mouse genomes. | 8.69e-05 | 3 | 188 | 2 | 12809675 | |
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 26770020 | ||
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 22451727 | ||
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 28975866 | ||
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 9971820 | ||
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 19527720 | ||
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 11703943 | ||
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 37332045 | ||
| Pubmed | Mapping of the glycoprotein 330 (Gp330) gene to mouse chromosome 2. | 8.69e-05 | 3 | 188 | 2 | 8244399 | |
| Pubmed | Snapshots of nascent RNA reveal cell- and stimulus-specific responses to acute kidney injury. | 8.69e-05 | 3 | 188 | 2 | 35230973 | |
| Pubmed | Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC). | 8.69e-05 | 3 | 188 | 2 | 24635038 | |
| Pubmed | Heparin enhances serpin inhibition of the cysteine protease cathepsin L. | 8.69e-05 | 3 | 188 | 2 | 19959474 | |
| Pubmed | c/ebpdelta Null mouse as a model for the double knock-out of slc5a8 and slc5a12 in kidney. | 8.69e-05 | 3 | 188 | 2 | 16873376 | |
| Pubmed | Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells. | 8.69e-05 | 3 | 188 | 2 | 19070595 | |
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 16391387 | ||
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 10516026 | ||
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 9828132 | ||
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 7724531 | ||
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 24898082 | ||
| Pubmed | The TPTE gene family: cellular expression, subcellular localization and alternative splicing. | 8.69e-05 | 3 | 188 | 2 | 14659893 | |
| Pubmed | Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. | 8.69e-05 | 3 | 188 | 2 | 15314180 | |
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 20560925 | ||
| Pubmed | A nonredundant role for mouse Serpinb3a in the induction of mucus production in asthma. | 8.69e-05 | 3 | 188 | 2 | 21126757 | |
| Pubmed | Developmental expression of PAM (protein associated with MYC) in the rodent brain. | 8.69e-05 | 3 | 188 | 2 | 12036515 | |
| Pubmed | Membrane detachment is not essential for COG complex function. | 8.69e-05 | 3 | 188 | 2 | 29467253 | |
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 26683461 | ||
| Pubmed | 8.69e-05 | 3 | 188 | 2 | 11278976 | ||
| Pubmed | Uteroglobin suppresses SCCA gene expression associated with allergic asthma. | 8.69e-05 | 3 | 188 | 2 | 15677460 | |
| Pubmed | Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of aurora B. | 1.73e-04 | 4 | 188 | 2 | 18728397 | |
| Pubmed | 1.73e-04 | 4 | 188 | 2 | 21849517 | ||
| Pubmed | 1.73e-04 | 4 | 188 | 2 | 26147384 | ||
| Pubmed | 1.73e-04 | 4 | 188 | 2 | 16549498 | ||
| GeneFamily | Solute carriers | SLC36A1 SLCO2B1 SLC6A17 SLC6A15 SLC46A1 SLC10A7 SLC29A2 SLC7A11 SLC18B1 SLC36A2 SLC26A8 SLC50A1 SLC2A6 SLCO1A2 SLC35F2 SLC5A12 SLC26A11 SLC16A10 | 1.83e-09 | 395 | 141 | 18 | 752 |
| GeneFamily | ATP binding cassette subfamily A | 1.59e-04 | 14 | 141 | 3 | 805 | |
| GeneFamily | Olfactory receptors, family 10 | 1.64e-04 | 66 | 141 | 5 | 157 | |
| GeneFamily | Serpin peptidase inhibitors | 1.92e-04 | 37 | 141 | 4 | 739 | |
| GeneFamily | ATPase phospholipid transporting | 1.97e-04 | 15 | 141 | 3 | 1210 | |
| GeneFamily | Fibronectin type III domain containing | 2.61e-04 | 160 | 141 | 7 | 555 | |
| GeneFamily | C2 tensin-type domain containing|PTEN protein phosphatases|Phosphoinositide phosphatases | 5.95e-04 | 5 | 141 | 2 | 902 | |
| GeneFamily | Components of oligomeric golgi complex | 1.64e-03 | 8 | 141 | 2 | 493 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.64e-03 | 8 | 141 | 2 | 837 | |
| GeneFamily | Patatin like phospholipase domain containing | 2.61e-03 | 10 | 141 | 2 | 466 | |
| GeneFamily | Pseudoautosomal region 2 | 2.61e-03 | 10 | 141 | 2 | 716 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-08 | 184 | 180 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-08 | 184 | 180 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-08 | 184 | 180 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | CRYBG2 ANPEP SPAG6 DNAH7 PTPRZ1 SERPINB4 DLEC1 CFAP61 CFAP44 | 1.20e-07 | 198 | 180 | 9 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | CRYBG2 ANPEP SPAG6 DNAH7 PTPRZ1 SERPINB4 DLEC1 CFAP61 CFAP44 | 1.20e-07 | 198 | 180 | 9 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-07 | 154 | 180 | 8 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-07 | 154 | 180 | 8 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-07 | 160 | 180 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-07 | 160 | 180 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.71e-07 | 178 | 180 | 8 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.01e-06 | 188 | 180 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Control-Myeloid-MoAM1|Control / Disease group,lineage and cell class （2021.01.30） | 1.05e-06 | 189 | 180 | 8 | 55d5c2fb9e6ab556d42c83a1e985ee66e4cf9dba | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.05e-06 | 189 | 180 | 8 | ebb5e069fdca7cf8ffac16a57572e92d2593c86a | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.05e-06 | 189 | 180 | 8 | a59e4eaff430a443f9fa7edabe64e66a15b6bffb | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-06 | 190 | 180 | 8 | 5c8aa310886c64ee5dce4ba46a3dd178da549529 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-06 | 190 | 180 | 8 | 4b4fe93061c87605dddf5bec94fa07c749c722aa | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.14e-06 | 191 | 180 | 8 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.23e-06 | 193 | 180 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.23e-06 | 193 | 180 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-06 | 195 | 180 | 8 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 1.38e-06 | 196 | 180 | 8 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-06 | 196 | 180 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-06 | 196 | 180 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-06 | 197 | 180 | 8 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-stromal_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.44e-06 | 197 | 180 | 8 | 72775eb6c24cfb956436642ac9cd6e4d5c01ea5f | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.44e-06 | 197 | 180 | 8 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-06 | 197 | 180 | 8 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-06 | 197 | 180 | 8 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-06 | 197 | 180 | 8 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-stromal_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.61e-06 | 200 | 180 | 8 | af743dfef7e7cfaef1c494999757123f93a213e3 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-06 | 145 | 180 | 7 | 47a3bb973a508d3097213a2d86ad1ce697af9bae | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.83e-06 | 169 | 180 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-06 | 170 | 180 | 7 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.79e-06 | 173 | 180 | 7 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 7.89e-06 | 177 | 180 | 7 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.05e-05 | 185 | 180 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 185 | 180 | 7 | 53a5218c1e6eb12daccde3d6e02f337e2586d74c | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.09e-05 | 186 | 180 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.21e-05 | 189 | 180 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-05 | 191 | 180 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-05 | 191 | 180 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.34e-05 | 192 | 180 | 7 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.34e-05 | 192 | 180 | 7 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 1.34e-05 | 192 | 180 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.38e-05 | 193 | 180 | 7 | 837c61408462c519912ecf3b83fdc72cd85fe88f | |
| ToppCell | Control-Myeloid-MoAM3|Control / Disease group,lineage and cell class （2021.01.30） | 1.38e-05 | 193 | 180 | 7 | 97d2f12be43fc26efa84ac4c6119132928a123de | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.38e-05 | 193 | 180 | 7 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.38e-05 | 193 | 180 | 7 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.38e-05 | 193 | 180 | 7 | d81840e1322507552b7726bf7828309375162324 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.38e-05 | 193 | 180 | 7 | e4ca3a3c2704cdc52e6ac3f25f14debf74226c29 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.38e-05 | 193 | 180 | 7 | e54f8b6381b5a96758cff41ab12d6f60cfca29a9 | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.43e-05 | 194 | 180 | 7 | a4523adbbd25c314809eed3414d66a5b323446e5 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.43e-05 | 194 | 180 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.43e-05 | 194 | 180 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.43e-05 | 194 | 180 | 7 | 125bf2909cf89133693bc7b865ca08955cf67a2e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 194 | 180 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-05 | 195 | 180 | 7 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.48e-05 | 195 | 180 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.48e-05 | 195 | 180 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.53e-05 | 196 | 180 | 7 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.58e-05 | 197 | 180 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.58e-05 | 197 | 180 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.63e-05 | 198 | 180 | 7 | fbd72ebaba73cc30e79dc8a8c3d46b6f863c1494 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-05 | 198 | 180 | 7 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.63e-05 | 198 | 180 | 7 | 641e7be258303bb9782d19fcf8693f317581d3b8 | |
| ToppCell | critical-Myeloid-Non-resident_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.69e-05 | 199 | 180 | 7 | 193325768b17d3123ae855317f381a01088b5dac | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.69e-05 | 199 | 180 | 7 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | IPF-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.69e-05 | 199 | 180 | 7 | 3c2b362d5e824e1a04830e70352f8818de984174 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.69e-05 | 199 | 180 | 7 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.74e-05 | 200 | 180 | 7 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-05 | 200 | 180 | 7 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.74e-05 | 200 | 180 | 7 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 1.74e-05 | 200 | 180 | 7 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-05 | 200 | 180 | 7 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.74e-05 | 200 | 180 | 7 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.18e-05 | 139 | 180 | 6 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 3.48e-05 | 151 | 180 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-05 | 152 | 180 | 6 | bd1f36b436d8ab7dd8420f595b97d851eab31a38 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-05 | 152 | 180 | 6 | ee329249a034a969a16b26a224aa04249d67382d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.02e-05 | 155 | 180 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.02e-05 | 155 | 180 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.02e-05 | 155 | 180 | 6 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-05 | 159 | 180 | 6 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-05 | 159 | 180 | 6 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.80e-05 | 160 | 180 | 6 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.15e-05 | 162 | 180 | 6 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.89e-05 | 166 | 180 | 6 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.89e-05 | 166 | 180 | 6 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 6.09e-05 | 167 | 180 | 6 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-05 | 168 | 180 | 6 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.51e-05 | 169 | 180 | 6 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.51e-05 | 169 | 180 | 6 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.51e-05 | 169 | 180 | 6 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 6.72e-05 | 170 | 180 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 6.94e-05 | 171 | 180 | 6 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.17e-05 | 172 | 180 | 6 | c3a99828838af3b85c8c885d69cc8018f55ced50 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 7.64e-05 | 174 | 180 | 6 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-Gamma_Delta_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.74e-05 | 108 | 180 | 5 | 04bfb90634b691020f246a8afbebd3bf944d1e0e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-05 | 175 | 180 | 6 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-05 | 175 | 180 | 6 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 9.62e-05 | 15 | 180 | 3 | EFO_0004599, EFO_0007892 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 1.70e-04 | 18 | 180 | 3 | EFO_0006831, EFO_0006896 | |
| Disease | skin pigmentation measurement | 2.01e-04 | 137 | 180 | 6 | EFO_0007009 | |
| Disease | PR interval | CRYBG2 KALRN MYCBP2 ABCA12 OBSCN SLC6A15 RYR2 SIPA1L1 ASTN2 DLEC1 ADGRL3 | 2.46e-04 | 495 | 180 | 11 | EFO_0004462 |
| Disease | kallikrein-13 measurement | 3.66e-04 | 5 | 180 | 2 | EFO_0020512 | |
| Disease | essential hypertension, age at diagnosis | 3.84e-04 | 56 | 180 | 4 | EFO_0004918, MONDO_0001134 | |
| Disease | aspartate aminotransferase measurement | PLB1 VMA21 ANPEP KALRN CETP OBSCN FAM227B KRT79 BIRC6 MFSD12 RGL1 USP8 OR4C3 ASTN2 SLC35F2 | 4.58e-04 | 904 | 180 | 15 | EFO_0004736 |
| Disease | phospholipase D3 measurement | 5.46e-04 | 6 | 180 | 2 | EFO_0802866 | |
| Disease | lipoprotein A measurement | 6.33e-04 | 112 | 180 | 5 | EFO_0006925 | |
| Disease | stimulant use measurement | 6.54e-04 | 28 | 180 | 3 | EFO_0600076 | |
| Disease | stromal cell-derived factor 1 measurement | 7.62e-04 | 7 | 180 | 2 | EFO_0020756 | |
| Disease | alpha-1-antichymotrypsin complex measurement | 7.62e-04 | 7 | 180 | 2 | EFO_0008018 | |
| Disease | amino acid measurement | FAT4 ABCA12 DNAH7 RYR2 MAP3K4 NRP2 RGL1 SUSD5 LRP2 ASTN2 HTT MGAM2 | 9.83e-04 | 678 | 180 | 12 | EFO_0005134 |
| Disease | kallistatin measurement | 1.01e-03 | 8 | 180 | 2 | EFO_0008196 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.01e-03 | 8 | 180 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | memory impairment | 1.01e-03 | 8 | 180 | 2 | EFO_0001072 | |
| Disease | blindness (implicated_via_orthology) | 1.01e-03 | 8 | 180 | 2 | DOID:1432 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 1.15e-03 | 261 | 180 | 7 | C0004352 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 1.49e-03 | 37 | 180 | 3 | EFO_0022281 | |
| Disease | Congenital disorder of glycosylation | 1.61e-03 | 38 | 180 | 3 | cv:C0282577 | |
| Disease | guilt measurement | 1.87e-03 | 40 | 180 | 3 | EFO_0009595 | |
| Disease | cholesterol in very small VLDL measurement | 1.87e-03 | 40 | 180 | 3 | EFO_0022231 | |
| Disease | response to ondansetron, QT interval | 1.96e-03 | 11 | 180 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.00e-03 | 145 | 180 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 2.35e-03 | 12 | 180 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | concentration of large LDL particles measurement | 2.46e-03 | 44 | 180 | 3 | EFO_0022160 | |
| Disease | cholesterol in medium VLDL measurement | 2.46e-03 | 44 | 180 | 3 | EFO_0022225 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 2.62e-03 | 45 | 180 | 3 | EFO_0022236 | |
| Disease | free cholesterol in very small VLDL measurement | 2.97e-03 | 47 | 180 | 3 | EFO_0022275 | |
| Disease | triacylglycerol 48:4 measurement | 3.21e-03 | 14 | 180 | 2 | EFO_0010407 | |
| Disease | phospholipids in medium LDL measurement | 3.35e-03 | 49 | 180 | 3 | EFO_0022183 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 3.35e-03 | 49 | 180 | 3 | EFO_0022256 | |
| Disease | diverticular disease | 3.36e-03 | 236 | 180 | 6 | EFO_0009959 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 3.75e-03 | 51 | 180 | 3 | EFO_0022242 | |
| Disease | Colorectal Carcinoma | KALRN ABCA12 RBM10 OBSCN LGR5 ADCY8 ABCA6 ABCA5 SACS SLCO1A2 LRP2 | 4.04e-03 | 702 | 180 | 11 | C0009402 |
| Disease | interleukin 1 receptor antagonist measurement | 4.18e-03 | 53 | 180 | 3 | EFO_0004754 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 4.18e-03 | 53 | 180 | 3 | EFO_0022340 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 4.18e-03 | 53 | 180 | 3 | EFO_0022258 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 4.41e-03 | 54 | 180 | 3 | EFO_0022244 | |
| Disease | Lipidemias | 4.74e-03 | 17 | 180 | 2 | C1706412 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 4.74e-03 | 17 | 180 | 2 | EFO_0022232 | |
| Disease | spinal stenosis | 4.74e-03 | 17 | 180 | 2 | EFO_0007490 | |
| Disease | Hyperlipidemia | 4.74e-03 | 17 | 180 | 2 | C0020473 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 4.88e-03 | 56 | 180 | 3 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 4.88e-03 | 56 | 180 | 3 | EFO_0022250 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 5.13e-03 | 57 | 180 | 3 | EFO_0022284 | |
| Disease | phosphatidylcholine 36:4 measurement | 5.31e-03 | 18 | 180 | 2 | EFO_0010382 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 5.31e-03 | 18 | 180 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 5.39e-03 | 58 | 180 | 3 | EFO_0022338 | |
| Disease | phospholipids in LDL measurement | 5.39e-03 | 58 | 180 | 3 | EFO_0022294 | |
| Disease | asthma, response to diisocyanate | 5.47e-03 | 261 | 180 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 5.65e-03 | 59 | 180 | 3 | EFO_0022289 | |
| Disease | metabolonic lactone sulfate measurement | 5.91e-03 | 19 | 180 | 2 | EFO_0800659 | |
| Disease | Hypertriglyceridemia | 5.91e-03 | 19 | 180 | 2 | EFO_0004211 | |
| Disease | Osteochondrodysplasias | 5.91e-03 | 19 | 180 | 2 | C0029422 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MLENYSSLVSLGIPF | 41 | Q86Y25 | |
| YGLSSVFFALMLTPL | 306 | Q8WWZ7 | |
| FTLFATYSMLPLPLT | 276 | P40145 | |
| DRISESYVTLFMSIP | 226 | Q96M60 | |
| IFLIVPSYMSLGSTL | 136 | Q8NHU2 | |
| PSYMSLGSTLITVFD | 141 | Q8NHU2 | |
| TFSPTLLGDSRMLYF | 266 | P11597 | |
| VASSVMDRLSYLLPS | 251 | Q9NR09 | |
| YGLILMSSFIFLSDT | 11 | Q8IZF6 | |
| FFSLTETPEDYTLMV | 41 | Q8WTX7 | |
| SLSPVIYDSLTGLMT | 666 | Q9H9E3 | |
| SQGITTEYLTAMLPS | 731 | Q86UK0 | |
| VFMSLLSPTAFSYAS | 1206 | Q86UK0 | |
| TKVLYFTDRSLTPFM | 601 | Q155Q3 | |
| ISRYSIMDASLPFTI | 2806 | Q6V0I7 | |
| ITTMVLVPSYTLLGF | 1156 | Q8N139 | |
| LYTSMPTLAGVAATE | 1356 | Q9HAR2 | |
| FDISSLMLYGTQAIP | 91 | Q01954 | |
| YLTFMEERGSPVSSL | 1146 | Q8NFD5 | |
| TTPKMSTYLLAFIVS | 271 | P15144 | |
| FLYADLSVMSSPSIL | 1176 | O60423 | |
| LLSSSVSFYLPLLVM | 206 | P13945 | |
| SSPQVMLLATYFLEL | 221 | Q9H8S5 | |
| VAVSPLTYLMATTAL | 476 | Q96MT7 | |
| LKSMPFITYLSGLLT | 946 | O75129 | |
| SLSPVTAAVYSFLTM | 351 | O60312 | |
| VFSSPAVYVLSLLEM | 76 | Q9BV10 | |
| MTASPDYLVVLFGIT | 1 | Q6NXG1 | |
| STMDSILGALAPYAV | 311 | P98175 | |
| GKVSSLFYTTVVPML | 271 | Q15620 | |
| TVPYLGTFLTDLTML | 416 | Q9NZL6 | |
| LPDDLYMSFLLTATL | 306 | Q6ZRI8 | |
| LMQDSAPTIATYLSL | 656 | Q96PE3 | |
| LGIYDMTSVLPSASA | 86 | Q6TCH7 | |
| STSSAVPLIGKYMLF | 286 | P02708 | |
| IGYSFIINMLLSPSA | 991 | Q7Z5J8 | |
| GLSTSIPLRMSSYTF | 21 | Q8WWY6 | |
| VMPYVIGFTSSLISV | 146 | Q8N0Y5 | |
| PYLLDTSTMPYLTET | 4401 | Q8WXI7 | |
| PFGAISSSVLLMIIY | 201 | Q0GE19 | |
| LDLTYPVTSMFTGSA | 1051 | Q8IY17 | |
| GDTLMATTYAVLTPF | 271 | O60403 | |
| FSSTTVPKMLFYLSG | 71 | Q8NGN7 | |
| ASYTLVLFTVLRMPS | 216 | A6NM03 | |
| TILSSPALLVSPMYF | 46 | Q8NGM1 | |
| LAMLTASGIFNSLYP | 401 | Q96NT5 | |
| SSLMSDFIFPTQSLL | 1396 | Q5T1H1 | |
| LTDFLSFYTLPSTVM | 396 | O60551 | |
| YLNTSITADLSLPMA | 961 | Q2M2H8 | |
| LLYSLAPTMGAVVLS | 366 | Q8NBP5 | |
| GLFLSSTFPSMLAYT | 411 | Q8N468 | |
| STFPSMLAYTEDSLQ | 416 | Q8N468 | |
| IEALSTLDSITLMYP | 96 | Q96QG7 | |
| TIMIAAVSPSSVFYD | 326 | Q8NI77 | |
| FSPIFLLSTSETMYS | 861 | Q9ULI0 | |
| FAIILLNTDMYSPSV | 886 | Q5JU85 | |
| LEPLFEAYLGSMRST | 191 | Q5XKE5 | |
| ATQDLILSGFYSIMP | 266 | Q8NHC7 | |
| YSTAFAPKMIVDLLS | 101 | Q8NGL6 | |
| LSIPFSSIYAMVLLG | 36 | Q9H2C8 | |
| YSSAVTPIVMAGFLI | 71 | Q8NH48 | |
| TYESPTSYILILELM | 2746 | O60229 | |
| PTIISSGSMLYIKFT | 111 | O60462 | |
| SYMLISAPAILGTSN | 396 | Q96MW5 | |
| TLGIPTYVMSNLFSI | 281 | P63132 | |
| SLPLLLLSMVAASYS | 6 | P11226 | |
| YSLPTMEILYSLEVS | 336 | P50748 | |
| NMDTASGLLSTTYLP | 731 | Q6ZVL6 | |
| VNSSLVMPSGLTLDY | 2546 | P98164 | |
| LFMTPYDFILAVTTD | 161 | Q86XE3 | |
| MLLIPFSVISGSYTR | 206 | Q8NH04 | |
| DKAVSAFYTILTPML | 271 | Q8NH04 | |
| ASSEMLSPSTQLLFY | 1156 | P23471 | |
| PSSYIALITMAILQS | 106 | Q12950 | |
| ATPQLMAVFGSLSLY | 171 | Q9UGQ3 | |
| TLGIPTYAMSNLFSI | 281 | P63135 | |
| TLGIPTYAMSNLFSI | 281 | Q9BXR3 | |
| AALDLTYPITSMFSG | 996 | Q6ZV29 | |
| IPYFAITTDITASAM | 1031 | Q6ZV29 | |
| PSELLTSVRAYMTVL | 736 | Q9Y2A7 | |
| LEVISIPAFLYSSML | 201 | A6NG13 | |
| TPGYSSLSVIEMILA | 46 | Q04941 | |
| FLTTYRVIFTGMPTD | 931 | O95248 | |
| MSFSSLPTEIQSLLF | 1 | Q9H208 | |
| LYPTISSDIRFTNML | 636 | O75400 | |
| TAFIMLSAEYPVSSE | 7856 | Q5VST9 | |
| TLGIPTYAMSNLFSI | 281 | Q9QC07 | |
| MVASFSYSPIRLLEV | 1376 | Q9Y2I7 | |
| LVSSMLESPISSLYQ | 96 | Q8NCM8 | |
| VMLSGSEESTPSIIY | 2861 | P42858 | |
| AYDTTSTTLPFIMYE | 306 | Q9HB55 | |
| FSAYIDSMAAVPTLE | 61 | P49716 | |
| SLLSEVTSGTYFPMA | 106 | Q9BQN1 | |
| YTIMVLFADQATPTS | 846 | P21333 | |
| SASLPESLYSLVMTY | 291 | O60883 | |
| GLPLAFLTAMQSSYI | 246 | O14681 | |
| QTSLEMFYSIDLSPV | 221 | Q6PGQ7 | |
| SPLFSTVTPEYMVLS | 666 | Q8N3K9 | |
| VSAMKTLYLADTFPT | 146 | P05154 | |
| SSYLSMYATLPAIEE | 791 | Q8N1P7 | |
| STVSSFLDMNLEPYI | 871 | Q8WXX0 | |
| STSPVSFIATYRLGM | 56 | Q14213 | |
| STSYIFPLFLTSGMT | 491 | P43251 | |
| LPVVMLSSVSDLLTY | 56 | P10911 | |
| SLEYNFVTPLTSLVM | 596 | Q6UXX5 | |
| SLPKTEMTSLSFLAF | 141 | Q92851 | |
| MTLVSPSLILYLNDT | 256 | O60383 | |
| TETLTAFLSYPTMDA | 5691 | Q8NDH2 | |
| TLSSVAPLLIEEYMS | 426 | A5D8W1 | |
| STIYISFTPMVLSPE | 1401 | Q9Y238 | |
| SSYTFSMDILKPGVS | 1881 | Q58EX2 | |
| SYVTPADIRSFLMTF | 3091 | Q9NZJ4 | |
| YTTVALLPMLSSLFE | 3096 | Q92736 | |
| VILPTSSTYISMVFD | 801 | Q6ZTR5 | |
| SSTYISMVFDSPTIG | 806 | Q6ZTR5 | |
| IPLVMYLSGFLSSFL | 316 | Q6NUT3 | |
| TQYSSAMLESLLPGI | 591 | P55786 | |
| PYLLAFTTDSMEIRL | 761 | Q5VVW2 | |
| PSNLSVFTSYLDLSM | 61 | O75473 | |
| TAFMYLKPSTISSLT | 271 | Q8NGG7 | |
| MLSTSETVYTLVILP | 76 | P30954 | |
| VLVSTDAALQSPMYF | 46 | Q96KK4 | |
| IFLTPLGFMTTSYVR | 206 | P58170 | |
| TVSISKSLDSPMYFF | 46 | Q8NGF8 | |
| FIDTFYSSSMAPKLI | 66 | Q8NH37 | |
| LPLSSILDTLDVMAY | 181 | P06865 | |
| STLGTAAYMAPEVIT | 1501 | Q9Y6R4 | |
| LAFMVPLGVITTSYL | 211 | Q8TDU9 | |
| VTMFDDYSATLPLLI | 521 | Q9H2J7 | |
| FITEESPMATLSYEL | 476 | O60279 | |
| VTNTLPVLLSLYMST | 376 | O75602 | |
| QLGTMPSTYSTLFLS | 151 | Q14542 | |
| TSLSLEATVMPYLQV | 576 | P49589 | |
| AASPRYIFTMLSTLA | 821 | Q02880 | |
| YIAVMDYLPISSTST | 341 | Q8N7P1 | |
| STFMYLTLDLPTAPL | 386 | Q53GS9 | |
| SVVSSMPFLQEDLYS | 2026 | O95425 | |
| VLSSVPLQMLFYLSG | 86 | Q96HE8 | |
| YLFMLLSDLPETLQT | 1761 | B5MCY1 | |
| VFLGMALSYAISSPL | 276 | Q6NT16 | |
| TSQTLIDMIPYSFLL | 331 | Q96RN1 | |
| FFSPLSISAAYAMLS | 76 | P29622 | |
| PSSMAKFTIEYLSLL | 881 | Q7RTY7 | |
| PAILSLGMSIVTSLY | 296 | Q495M3 | |
| LEVTTFYSEGMSPLT | 426 | Q495M3 | |
| LSPGSDIYVTVSSMA | 1126 | O43166 | |
| FSLRSYQTETLPMIL | 136 | A0PJX4 | |
| SSSLFSMLLPLIIAY | 1941 | O75592 | |
| ISSISPMLNSFIYTL | 276 | A6NDL8 | |
| LSAMSSFIYSLAAIP | 516 | P46721 | |
| ALEPMTTLLSYELAF | 171 | Q01113 | |
| VMTVLSDIIRYFSPS | 106 | Q6P1J6 | |
| YSFMPLVIKVTSATS | 276 | Q8IXU6 | |
| NIFYSPISITSALGM | 26 | P29508 | |
| TLSEDMILLTFPFSA | 771 | O60287 | |
| LSEELFQMLYPATTS | 156 | Q8NCR9 | |
| NISFTSLPILLYSLM | 921 | P98196 | |
| EETVTTILGMLASPY | 196 | Q9UBN6 | |
| TLGIPTYAMSNLFSI | 281 | P63136 | |
| LRLFFMYTTSSILGP | 511 | P48995 | |
| EDFLLTYRTFLSSPM | 296 | Q9Y4G8 | |
| FLIATSSYFMPETEL | 251 | Q9NYW3 | |
| LFMVALSLYSDPFST | 436 | Q9UPY5 | |
| ITDLSLPNYLMASSV | 266 | Q6YI46 | |
| YVTERIIAMSFPSSG | 241 | P56180 | |
| PLYEIVIFTSETGMT | 186 | Q3ZCQ8 | |
| VTTFYSEGMSPLTIF | 421 | Q7Z2H8 | |
| TLGPTAIMSLLVSFY | 101 | Q86WA9 | |
| SNSPLYLGILFAVTM | 221 | O94956 | |
| VTTAPGIYSSTEMLD | 316 | Q92545 | |
| ESGYIFTLLFMPSTS | 496 | Q92545 | |
| FTISMYLSPLADLAK | 136 | Q9BRV3 | |
| TLGIPTYAMSNLFSI | 281 | P10266 | |
| ALSMAFYSSPEILRV | 261 | Q2MV58 | |
| TLGIPTYAMSNLFSI | 281 | P63133 | |
| MDLTAIYESLLSLSP | 1 | P26651 | |
| FIPTLSTVMGTSTEY | 1036 | Q6ZS81 | |
| YSSDMLQDTVVPLFS | 356 | Q9H3S3 | |
| TLGIPTYAMSNLFSI | 281 | Q9UQG0 | |
| NIFYSPISITSALGM | 26 | P48594 | |
| AITDFLLGFTIMPYS | 86 | Q9P1P5 | |
| YSEVLGRPTTLFETM | 236 | O75310 | |
| TALPYAMNSEFSSVL | 96 | P51809 | |
| GSVLTYIFMIDVSLP | 1506 | Q14997 | |
| GTKYLSTFSALTPVM | 396 | Q9Y577 | |
| VVNLPLVSSTYDLMS | 16 | Q99541 | |
| TMFDDYSATLPLTLI | 521 | Q9H1V8 | |
| LTYVTERIIAMSFPS | 221 | Q6XPS3 | |
| LMITVPIGLYFTTKS | 36 | Q3ZAQ7 | |
| YSEVLGRPTTLFETM | 236 | Q9BY64 | |
| FMSAVTVLGTPSEVY | 61 | Q1EHB4 | |
| FEAFMYLSLPLASTS | 946 | P40818 | |
| MLEVFSSENTYLPVL | 171 | Q15386 | |
| LSTLPYTMISTLATF | 171 | Q9P2D8 | |
| YLSTSFLPMAILGSS | 196 | Q9P2D8 | |
| MVPLFITSDSALTYS | 1 | Q6ZPA2 | |
| LMSSSFVSSIEPLYL | 156 | Q8TF71 | |
| TFYISPGSMETTLAS | 4856 | Q9UKN1 | |
| EIMYQPSSLLFIIDS | 246 | Q86W24 |